XiFin Secures Growth Investment
XiFin, a San Diego, CA-based provider of AI-enhanced revenue cycle management (RCM) and billing solutions, has secured growth capital.
The round was led by Goldman Sachs External Investing Group, with participation from Avista Healthcare Partners and other institutional investors.
Goldman Sachs is a global financial institution with over $500 billion in alternative investments and more than 30 years of experience. It invests across private equity, growth equity, private credit, real estate, infrastructure, sustainability, and hedge funds, offering solutions through direct strategies, customized partnerships, and open-architecture programs. Founded in 1869 and headquartered in New York, Goldman Sachs serves corporations, financial institutions, governments, and individuals worldwide, with offices in all major financial centers.
The investment will provide XiFin with financial flexibility to expand its next-generation RCM solutions, pursue growth opportunities, and continue advancing AI-driven healthcare innovations.
XiFin is a healthcare technology company specializing in revenue cycle management (RCM) and billing solutions powered by embedded artificial intelligence. Its flagship platform, XiFin Empower, unifies automation, analytics, and interoperability to streamline workflows, improve financial performance, and enhance patient and provider experiences. XiFin’s mission is to create innovative technologies and services that optimize healthcare operations and deliver better care. Headquartered in San Diego, California, XiFin serves hospitals, health systems, pharmacies, diagnostics, and pharmaceutical companies
Funding Details
Company: XiFin, Inc.
Raised: Undisclosed
Round: Growth Investment
Funding Date: September 2025
Lead Investor: Goldman Sachs External Investing Group
Additional Investors: Avista Healthcare Partners
Company Website: https://www.xifin.com/
Software Category: HealthTech / Revenue Cycle Management / AI in Healthcare